Table 2.
HCV negative recipients (N = 921) | HCV positive recipients (N = 865) | |||
---|---|---|---|---|
No DGF | DGF | No DGF | DGF | |
N = 660 | N = 261 | N = 670 | N = 195 | |
Unknown | 185 (28.0%) | 71 (27.2%) | 194 (29.0%) | 33 (16.9%) |
Infection | 127 (19.2%) | 68 (26.1%) | 131 (19.6%) | 54 (27.7%) |
Cardiovascular | 102 (15.5%) | 43 (16.5%) | 74 (11.0%) | 29 (14.9%) |
Malignancy | 73 (11.1%) | 10 (3.8%) | 73 (10.9%) | 13 (6.7%) |
Respiratory failure | 36 (5.5%) | 19 (7.3%) | 18 (2.7%) | 7 (3.6%) |
Liver graft failure | 31 (4.7%) | 11 (4.2%) | 61 (9.1%) | 19 (9.7%) |
Kidney graft failure | 18 (2.7%) | 2 (0.8%) | 26 (3.9%) | 4 (2.1%) |
Hemorrhage | 13 (2.0%) | 7 (2.7%) | 16 (2.4%) | 3 (1.5%) |
Trauma | 4 (0.6%) | 2 (0.8%) | 6 (0.9%) | 0 (0.0%) |
Other | 71 (10.8%) | 28 (10.7%) | 71 (10.6%) | 33 (16.9%) |